SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

Core Insights - SS Innovations International, Inc. reported strong growth in SSi Mantra installations, procedures, and revenues for the fourth quarter and full year of 2025, highlighting significant market share gains in India and expansion into new global markets [4][5][6]. Financial Performance - Fourth quarter revenue increased by 79.1% to $14.5 million from $8.1 million in Q4 2024, with gross profit rising 60.7% to $6.4 million [5][7]. - For the full year 2025, total revenue reached $42.5 million, a 105.7% increase from $20.6 million in 2024, with gross profit up 131.2% to $19.5 million [5][9]. - The company reported a net loss of $2.5 million in Q4 2025, compared to a net loss of $1.9 million in Q4 2024, and a full-year net loss of $12.1 million, an improvement from a net loss of $19.2 million in 2024 [5][9]. Operational Highlights - SSi Mantra installations totaled 40 in Q4 2025, an increase of 81.8% from 22 installations in Q4 2024, and 103 installations for the full year, up 119.1% from 47 in 2024 [5][9]. - Cumulative surgeries reached 7,885, including 120 telesurgeries, with significant growth in various surgical procedures [5][9]. Strategic Initiatives - The company completed a private placement of common stock, generating approximately $18.6 million in gross proceeds to support growth initiatives [4][10]. - SS Innovations is progressing towards FDA approval for the SSi Mantra surgical robotic system and aims to obtain CE marking certification in the EU within the year [4][10]. Market Positioning - The company has gained significant share in the surgical robotics market in India and is preparing for entry into the U.S. and EU markets, enhancing its global presence [4][10]. - The SSi Mantra system is designed to be user-friendly and cost-effective, with advanced technology features aimed at making robotic surgery more accessible [12][11].